Cyclo Therapeutics Inc logo

Cyclo Therapeutics Inc

$ 1.96 -0.07 (-3.45%) 08:08 PM EST
P/E:
At Loss
P/B:
1.64
Market Cap:
$ 16.05M
Enterprise V:
$ 9.69M
Volume:
52.55K
Avg Vol (2M):
27.21K
Volume:
52.55K
Market Cap $:
16.05M
PE Ratio:
At Loss
Avg Vol (2-Month):
27.21K
Enterprise Value $:
9.69M
PB Ratio:
1.64
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.
Name Current Vs Industry Vs History
Cash-To-Debt 745.3
Equity-to-Asset 0.82
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.02
Distress
Grey
Safe
Beneish M-Score -1.36
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 72.2
9-Day RSI 58.86
14-Day RSI 52.84
6-1 Month Momentum % -20.14
12-1 Month Momentum % -66.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.6
Quick Ratio 5.48
Cash Ratio 3.55
Days Inventory 494.15
Days Sales Outstanding 65.89
Days Payable 5876.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -110

Financials (Next Earnings Date:2022-11-15 Est.)

CYTH's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CYTH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.726
EPS (TTM) ($) -1.68
Beta -1.16
Volatility % 34
14-Day RSI 52.84
14-Day ATR ($) 0.163981
20-Day SMA ($) 1.92611
12-1 Month Momentum % -66.72
52-Week Range ($) 1.69 - 8.3
Shares Outstanding (Mil) 8.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cyclo Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Cyclo Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.